| Jeffrey M Leiden, MD | |
|
Abbott Laboratories, 100 Abbott Park Road, Abbott Park, IL 60064-6020 | |
| (847) 938-9313 | |
| Not Available |
| Full Name | Jeffrey M Leiden |
|---|---|
| Gender | Male |
| Speciality | Internal Medicine - Cardiovascular Disease |
| Location | Abbott Laboratories, Abbott Park, Illinois |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1851516215 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RC0000X | Internal Medicine - Cardiovascular Disease | 50631 (Massachusetts) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Jeffrey M Leiden, MD 196 Beach Rd, Glencoe, IL 60022-1355 Ph: (847) 938-9313 | Jeffrey M Leiden, MD Abbott Laboratories, 100 Abbott Park Road, Abbott Park, IL 60064-6020 Ph: (847) 938-9313 |
News Archive
Cardiovascular disease has become the leading cause of death for those living with HIV, as the infection has moved from a terminal disease to a chronic illness.
"The governments of the United States, India, and Ethiopia will in collaboration with UNICEF convene the Child Survival Call to Action in Washington, D.C.," a two-day event beginning Thursday, which "brings together 700 leaders and global experts to launch a sustained effort to save children's lives," a UNICEF press release reports.
Preferences in the race of sexual partners influenced by subtle racism may perpetuate HIV-related health disparities. Black gay men have less choice when it comes to sexual partners than other groups and, as a result, their sexual networks are closely knit.
XenoPort, Inc. announced today that it has initiated a Phase 2b clinical trial of arbaclofen placarbil (AP), also known as XP19986, in patients with gastroesophageal reflux disease (GERD) who remain symptomatic despite treatment with a proton pump inhibitor (PPI). The trial is a multi-center, randomized, double-blind, placebo-controlled study designed to assess the efficacy and safety of AP as adjunctive therapy to PPIs.
Southern Research scientists are exploring how a mutated protein implicated in prostate cancer plays a role in the development of the disease and whether it holds a key to better treatment outcomes.
› Verified 2 days ago
Dr. Laura Ann Williams, MD, MPH Cardiovascular Disease Medicare: Not Enrolled in Medicare Practice Location: 200 Abbott Park Rd, Abbott Park, IL 60064 Phone: 847-935-8755 Fax: 847-936-0226 | |
Dr. Jaclyn Kay Anderson, DO, MS Cardiovascular Disease Medicare: Not Enrolled in Medicare Practice Location: 200 Abbott Park Rd, Dept. R4ne, Bldg. Ap34-2, Abbott Park, IL 60064 Phone: 847-938-0133 | |
Armenak Asatryan, M.D. Cardiovascular Disease Medicare: Medicare Enrolled Practice Location: 200 Abbott Park Rd, Ap 34 - 2, Dept R4rc, Abbott Park, IL 60064 Phone: 847-936-0554 |